
As of 30-JUN-2026, promoters held 52.40% of Entero Healthcare Solutions (-0.02 pp from 31-MAR-2026), foreign institutional investors 4.37%, domestic institutions 15.48% and the public 27.75%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Promoters held 52.40% of Entero Healthcare Solutions as of 30-JUN-2026, down 0.02 pp from 52.42% in 31-MAR-2026.
Foreign institutional investors held 4.37% of Entero Healthcare Solutions as of 30-JUN-2026, a change of +0.34 pp from the previous quarter.
Domestic institutional investors, including mutual funds and insurers, held 15.48% of Entero Healthcare Solutions as of 30-JUN-2026 (-1.14 pp from the previous quarter).
As of 30-JUN-2026, Entero Healthcare Solutions' shareholders were promoters (52.40%), foreign institutional investors 4.37%, domestic institutions 15.48% and the public 27.75%, as filed with the stock exchanges.
Track ENTERO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.